Catalyst Wire Dossier Catalyst Wire Dossier

Dapagliflozin (generic)

dapagliflozin · Cipla USA Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dapagliflozin (generic), covering 2026-04-06 to 2026-04-06. Get the full timeline:

Most recent: FDA Approved: DAPAGLIFLOZIN — Original Application (Cipla USA Inc.)

See pricing